HOLX's Diagnostics unit faces COVID-19 test declines, but Panther Fusion expansion, new assays and AI-driven Genius system support long-term growth potential.

Insight Molecular Diagnostics completes major milestones to support GraftAssureDx test kit trial for in vitro diagnostic for US FDA submission: Nashville, Tennessee Thursday, Marc ...

Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

The NASH Biomarkers Market sees major opportunities in non-invasive diagnostics combining serum markers, imaging, and AI for metabolic disease management. Key growth drivers include the demand for ...

SkylineDx today announced the launch of the Guideline-Informed Risk Assessment Initiative, a clinical program designed to support surgeons and multidisciplinary teams in evaluating patients with T1 ...